Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Amlodipine Besylate; Atorvastatin Calcium Patent Expiration

Amlodipine Besylate; Atorvastatin Calcium is used for treating hypercholesterolemia, hyperlipidemia, and hypertension. It was first introduced by Pharmacia And Upjohn Co Llc in its drug Caduet on Jan 30, 2004. 6 different companies have introduced drugs containing Amlodipine Besylate; Atorvastatin Calcium.


Amlodipine Besylate; Atorvastatin Calcium Patents

Given below is the list of patents protecting Amlodipine Besylate; Atorvastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Caduet US6455574 Therapeutic combination Aug 11, 2018

(Expired)

 Pharmacia
Caduet US5969156

(Pediatric)

 Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) Jan 08, 2017

(Expired)

 Pharmacia
Caduet US5969156 Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) Jul 08, 2016

(Expired)

 Pharmacia
Caduet US5686104

(Pediatric)

 Stable oral CI-981 formulation and process of preparing same May 11, 2015

(Expired)

 Pharmacia
Caduet US5686104 Stable oral CI-981 formulation and process of preparing same Nov 11, 2014

(Expired)

 Pharmacia
Caduet US6126971

(Pediatric)

 Stable oral CI-981 formulation and process for preparing same Jul 19, 2013

(Expired)

 Pharmacia
Caduet US6126971 Stable oral CI-981 formulation and process for preparing same Jan 19, 2013

(Expired)

 Pharmacia



Amlodipine Besylate; Atorvastatin Calcium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amlodipine Besylate; Atorvastatin Calcium Generic API Manufacturers

Several generic applications have been filed for Amlodipine Besylate; Atorvastatin Calcium. The first generic version for Amlodipine Besylate; Atorvastatin Calcium was by Mylan Pharmaceuticals Inc and was approved on Nov 29, 2013. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on May 22, 2025.

Given below is the list of companies who have filed for Amlodipine Besylate; Atorvastatin Calcium generic, along with the locations of their manufacturing plants worldwide.